ArticleFuture oncology (London, England)Published
Effectiveness of daratumumab plus bortezomib, lenalidomide, and dexamethasone (DVRd) versus VRd for transplant-eligible newly diagnosed multiple myeloma
Regional connection
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
- Institution
- Johnson & Johnson
- County
- Montgomery County
Publication record
- Type
- Article
- Venue
- Future oncology (London, England)
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Multiple Myeloma; Dexamethasone; Antineoplastic Combined Chemotherapy Protocols; Antibodies, Monoclonal; Treatment Outcome; Retrospective Studies; Adult; Aged; Middle Aged; Female; Male
- PubMed ID
- 42444515
- PubMed Central ID
- PMC13580475
- Open access
- Yes, open
- Added to directory
- Source checked